Elacridar

DB04881

small molecule investigational

Deskripsi

Elacridar (GW120918) is an oral bioenhancer that targets multiple drug resistance in tumors. In many cases, the appearance of multidrug resistance in cancer is due to a change in expression of protein inhibitors. As of August 2007 elacridar was not listed on GSK's product pipeline. Development is assumed to have been discontinued.

Struktur Molekul 2D

Berat 563.6429
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

212 Data
Afatinib The serum concentration of Afatinib can be increased when it is combined with Elacridar.
Bosutinib The serum concentration of Bosutinib can be increased when it is combined with Elacridar.
Brentuximab vedotin The serum concentration of Brentuximab vedotin can be increased when it is combined with Elacridar.
Colchicine The serum concentration of Colchicine can be increased when it is combined with Elacridar.
Edoxaban The serum concentration of Edoxaban can be increased when it is combined with Elacridar.
Ledipasvir The serum concentration of Ledipasvir can be increased when it is combined with Elacridar.
Naloxegol The serum concentration of Naloxegol can be increased when it is combined with Elacridar.
Pazopanib The serum concentration of Pazopanib can be increased when it is combined with Elacridar.
Prucalopride The serum concentration of Prucalopride can be increased when it is combined with Elacridar.
Ranolazine The serum concentration of Ranolazine can be increased when it is combined with Elacridar.
Silodosin The excretion of Silodosin can be decreased when combined with Elacridar.
Topotecan The serum concentration of Topotecan can be increased when it is combined with Elacridar.
Everolimus The serum concentration of Everolimus can be increased when it is combined with Elacridar.
Rifaximin The serum concentration of Rifaximin can be increased when it is combined with Elacridar.
Vincristine The excretion of Vincristine can be decreased when combined with Elacridar.
Doxorubicin The serum concentration of Doxorubicin can be increased when it is combined with Elacridar.
Betrixaban The serum concentration of Betrixaban can be increased when it is combined with Elacridar.
Folic acid Elacridar may decrease the excretion rate of Folic acid which could result in a higher serum level.
Allopurinol Elacridar may decrease the excretion rate of Allopurinol which could result in a higher serum level.
Raloxifene Elacridar may decrease the excretion rate of Raloxifene which could result in a higher serum level.
Celecoxib Elacridar may decrease the excretion rate of Celecoxib which could result in a higher serum level.
Oxaliplatin Elacridar may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.
Fluorouracil Elacridar may decrease the excretion rate of Fluorouracil which could result in a higher serum level.
Testosterone Elacridar may decrease the excretion rate of Testosterone which could result in a higher serum level.
Clofarabine Elacridar may decrease the excretion rate of Clofarabine which could result in a higher serum level.
Nitrofurantoin Elacridar may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
Riluzole Elacridar may decrease the excretion rate of Riluzole which could result in a higher serum level.
Sulfasalazine Elacridar may decrease the excretion rate of Sulfasalazine which could result in a higher serum level.
Glyburide Elacridar may decrease the excretion rate of Glyburide which could result in a higher serum level.
Tegaserod Elacridar may decrease the excretion rate of Tegaserod which could result in a higher serum level.
Leflunomide Elacridar may decrease the excretion rate of Leflunomide which could result in a higher serum level.
Rosuvastatin Elacridar may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Alvocidib Elacridar may decrease the excretion rate of Alvocidib which could result in a higher serum level.
Teriflunomide Elacridar may decrease the excretion rate of Teriflunomide which could result in a higher serum level.
Riociguat Elacridar may decrease the excretion rate of Riociguat which could result in a higher serum level.
Palbociclib Elacridar may decrease the excretion rate of Palbociclib which could result in a higher serum level.
Fimasartan Elacridar may decrease the excretion rate of Fimasartan which could result in a higher serum level.
Delafloxacin Elacridar may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Glasdegib Elacridar may decrease the excretion rate of Glasdegib which could result in a higher serum level.
Brigatinib Elacridar may decrease the excretion rate of Brigatinib which could result in a higher serum level.
Enasidenib Elacridar may decrease the excretion rate of Enasidenib which could result in a higher serum level.
Testosterone cypionate Elacridar may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level.
Testosterone enanthate Elacridar may decrease the excretion rate of Testosterone enanthate which could result in a higher serum level.
Darolutamide Elacridar may decrease the excretion rate of Darolutamide which could result in a higher serum level.
Tazemetostat Elacridar may decrease the excretion rate of Tazemetostat which could result in a higher serum level.
Conjugated estrogens Elacridar may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Gefitinib Elacridar may decrease the excretion rate of Gefitinib which could result in a higher serum level.
Cerivastatin Elacridar may decrease the excretion rate of Cerivastatin which could result in a higher serum level.
Teniposide Elacridar may decrease the excretion rate of Teniposide which could result in a higher serum level.
Prazosin Elacridar may decrease the excretion rate of Prazosin which could result in a higher serum level.
Zidovudine Elacridar may decrease the excretion rate of Zidovudine which could result in a higher serum level.
Ritonavir Elacridar may decrease the excretion rate of Ritonavir which could result in a higher serum level.
Methotrexate Elacridar may decrease the excretion rate of Methotrexate which could result in a higher serum level.
Ivermectin Elacridar may decrease the excretion rate of Ivermectin which could result in a higher serum level.
Imatinib Elacridar may decrease the excretion rate of Imatinib which could result in a higher serum level.
Sumatriptan Elacridar may decrease the excretion rate of Sumatriptan which could result in a higher serum level.
Tamoxifen Elacridar may decrease the excretion rate of Tamoxifen which could result in a higher serum level.
Mycophenolate mofetil Elacridar may decrease the excretion rate of Mycophenolate mofetil which could result in a higher serum level.
Daunorubicin Elacridar may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Lamivudine Elacridar may decrease the excretion rate of Lamivudine which could result in a higher serum level.
Irinotecan Elacridar may decrease the excretion rate of Irinotecan which could result in a higher serum level.
Donepezil Elacridar may decrease the excretion rate of Donepezil which could result in a higher serum level.
Ezetimibe Elacridar may decrease the excretion rate of Ezetimibe which could result in a higher serum level.
Mitoxantrone Elacridar may decrease the excretion rate of Mitoxantrone which could result in a higher serum level.
Camptothecin Elacridar may decrease the excretion rate of Camptothecin which could result in a higher serum level.
Nilotinib Elacridar may decrease the excretion rate of Nilotinib which could result in a higher serum level.
Tenofovir alafenamide The serum concentration of Tenofovir alafenamide can be increased when it is combined with Elacridar.
Revefenacin Elacridar may decrease the excretion rate of Revefenacin which could result in a higher serum level.
Tucatinib Elacridar may decrease the excretion rate of Tucatinib which could result in a higher serum level.
Selumetinib Elacridar may decrease the excretion rate of Selumetinib which could result in a higher serum level.
Pralatrexate Elacridar may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Ripretinib Elacridar may decrease the excretion rate of Ripretinib which could result in a higher serum level.
Fostemsavir Elacridar may decrease the excretion rate of Fostemsavir which could result in a higher serum level.
Ponatinib Elacridar may decrease the excretion rate of Ponatinib which could result in a higher serum level.
Trilaciclib Elacridar may decrease the excretion rate of Trilaciclib which could result in a higher serum level.
Pravastatin Elacridar may decrease the excretion rate of Pravastatin which could result in a higher serum level.
Sildenafil The serum concentration of Sildenafil can be increased when it is combined with Elacridar.
Morphine The serum concentration of Morphine can be increased when it is combined with Elacridar.
Tenofovir disoproxil The serum concentration of Tenofovir disoproxil can be increased when it is combined with Elacridar.
Clobazam The serum concentration of Clobazam can be increased when it is combined with Elacridar.
Quinine The serum concentration of Quinine can be increased when it is combined with Elacridar.
Toremifene The serum concentration of Toremifene can be increased when it is combined with Elacridar.
Bisoprolol The serum concentration of Bisoprolol can be increased when it is combined with Elacridar.
Simvastatin The serum concentration of Simvastatin can be increased when it is combined with Elacridar.
Mannitol The serum concentration of Mannitol can be increased when it is combined with Elacridar.
Loperamide The excretion of Loperamide can be decreased when combined with Elacridar.
Vardenafil The serum concentration of Vardenafil can be increased when it is combined with Elacridar.
Clomifene The serum concentration of Clomifene can be increased when it is combined with Elacridar.
Fexofenadine The serum concentration of Fexofenadine can be increased when it is combined with Elacridar.
Saquinavir The serum concentration of Saquinavir can be increased when it is combined with Elacridar.
Sitagliptin The serum concentration of Sitagliptin can be increased when it is combined with Elacridar.
Posaconazole The serum concentration of Posaconazole can be increased when it is combined with Elacridar.
Paliperidone The serum concentration of Paliperidone can be increased when it is combined with Elacridar.
Belinostat The serum concentration of Belinostat can be increased when it is combined with Elacridar.
Indacaterol The serum concentration of Indacaterol can be increased when it is combined with Elacridar.
Telaprevir The serum concentration of Telaprevir can be increased when it is combined with Elacridar.
Rivaroxaban Elacridar may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.
Simeprevir Elacridar may decrease the excretion rate of Simeprevir which could result in a higher serum level.
Ambrisentan The serum concentration of Ambrisentan can be increased when it is combined with Elacridar.
Apixaban Elacridar may decrease the excretion rate of Apixaban which could result in a higher serum level.

Target Protein

ATP-dependent translocase ABCB1 ABCB1

Referensi & Sumber

Artikel (PubMed)
  • PMID: 17932689
    Hubensack M, Muller C, Hocherl P, Fellner S, Spruss T, Bernhardt G, Buschauer A: Effect of the ABCB1 modulators elacridar and tariquidar on the distribution of paclitaxel in nude mice. J Cancer Res Clin Oncol. 2008 May;134(5):597-607. Epub 2007 Oct 12.
  • PMID: 17936633
    Colabufo NA, Berardi F, Cantore M, Perrone MG, Contino M, Inglese C, Niso M, Perrone R, Azzariti A, Simone GM, Porcelli L, Paradiso A: Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives. Bioorg Med Chem. 2008 Jan 1;16(1):362-73. Epub 2007 Sep 25.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul